In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
The activities of 11 antimicrobial agents against 36 strains of Campylobacter fetus subsp. jejuni were studied by a broth microdilution method. All strains were susceptible to 7 of the 11 antimicrobial agents. Of the newer agents tested N-formimidoyl thienamycin (MK0787) and rosaramicin had very good activity, whereas cefotaxime, moxalactam, and cefoperazone had poorer activity.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects*; D002169:Campylobacter Infections / Q000382:microbiology; D002168:Campylobacter fetus / Q000187:drug effects*; D002438:Cefoperazone; D002511:Cephalosporins / Q000494:pharmacology; D002645:Chickens; D006801:Humans; D015378:Imipenem; D007769:Lactams / Q000494:pharmacology; D007933:Leucomycins / Q000494:pharmacology; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007769:Lactams; D007933:Leucomycins; D015378:Imipenem; D002438:Cefoperazone